J R Soc Med 2006;99:220
doi:10.1258/jrsm.99.5.220-a
© 2006 Royal Society of Medicine
Inadvertent toxic drug reaction in the management of atrial fibrillation
Oscar Jolobe
Tameside General Hospital, Ashton-under-Lyne OL6 9RW, UK
E-mail:
oscarjolobe{at}yahoo.co.uk
The choice of either sotalol or amiodarone for rhythm control was a feature
of the management of a case presented by Leaver and Ho (March 2006
JRSM1)
which was even more problematic than the inadvertent choice of adversely
interacting drugs. Although amiodarone was the final choice of antiarrhythmic
agent, presumably because of its superior efficacy in preventing relapse of
atrial fibrillation
(AF),2 it is a drug
now known to be associated with relapse rates of the order of
>90%.3,4
Accordingly, so long as the long-term antiarrhythmic management of AF involves
drugs, which are not strikingly superior to amiodarone in their
efficacyeven with the benefit of adjunctive electrical
cardio-version3the
verdict from the AFFIRM
study5 will prevail.
In paraphrase, the verdict from AFFIRM is that failed rhythm control is a poor
substitute for successful rate control.
REFERENCES
- Leaver S, Ho TB. Inadvertent toxic drug reaction in the management
of atrial fibrillation. J R Soc Med2006; 99:149
-50[Free Full Text]
- Singh BN, Singh SN, Reda SJ, et al. Amiodarone v sotalol
for atrial fibrillation. N Engl J Med2005; 352:1861
-72[Abstract/Free Full Text]
- Oral H, Pappone C, Chugh A, et al. Circumferential
pulmonaryvein ablation for chronic atrial fibrillation. N
Engl J Med 2006;354:934
-41[Abstract/Free Full Text]
- Stabile G, Bertaglia E, Senatore G, et al. Catheter
ablation treatment in patients with drug-refractory atrial fibrillation: a
prospective, multicentre, randomised, controlled study (Catheter Ablation For
the Cure of Atrial Fibrillation study). Eur Heart J2006; 27:216
-21[Abstract/Free Full Text]
- The Atrial Fibrillation Follow-up Investigation of Rhythm
Management (AFFIRM) Investigators. A comparison of rate control and rhythm
control in patients with atrial fibrillation. N Engl J
Med 2002;347:1825
-33[Abstract/Free Full Text]

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?